18F-FLT PET/MRI for bone marrow failure syndrome-initial experience View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-12

AUTHORS

Tetsuya Tsujikawa, Toshiki Tasaki, Naoko Hosono, Tetsuya Mori, Akira Makino, Yasushi Kiyono, Paolo Zanotti-Fregonara, Takahiro Yamauchi, Hidehiko Okazawa

ABSTRACT

BACKGROUND: Bone marrow failure syndrome (BMFS) is a heterogeneous group of disorders associated with single- or multiple-lineage cytopenia and failure of normal hematopoiesis. We assessed the feasibility of integrated PET/MRI with 3'-deoxy-3'-18F-fluorothymidine (18F-FLT) to assess the pathophysiology of whole-body bone marrow for the diagnosis and monitoring of BMFS. Twenty-five consecutive patients with BMFS underwent a pre-treatment 18F-FLT PET/MRI scan. They included 7 patients with aplastic anemia (AA), 16 with myelodysplastic syndrome (MDS), and 2 with myeloproliferative neoplasms (MPNs), primary myelofibrosis (MF), and secondary [post-essential thrombocythemia (post-ET)] MF. Two of the seven AA patients underwent a post-treatment scan. Eight of the 16 MDS patients who exhibited decreased 18F-FLT uptake in the pelvis were considered to have hypoplastic MDS (hypo-MDS). 18F-FLT PET and diffusion-weighted imaging (DWI) were visually and quantitatively evaluated. RESULTS: The 18F-FLT uptake in the ilium was strongly correlated with bone marrow cellularity based on biopsy samples (ρ = 0.85). AA patients exhibited heterogeneously decreased uptake of 18F-FLT according to disease severity. Multiple 18F-FLT foci were observed in the proximal extremities, and they were in the central skeleton in severe AA patients. Post-treatment 18F-FLT PET scans of severe AA patients reflected the response of hematopoietic activity to treatment. MDS patients had marked 18F-FLT uptake in the central skeleton and proximal extremities, whereas hypo-MDS patients had heterogeneously decreased uptake, similar to that of non-severe AA patients. 18F-FLT PET and DWI were unable to predict the progression to leukemia for both MDS and hypo-MDS patients. A primary MF patient had slightly decreased 18F-FLT uptake in the central skeleton, but marked expansion of bone marrow activity to the distal extremities and high uptake of tracer in the extremely enlarged spleen (extramedullary hematopoiesis). In contrast, a secondary (post-ET) MF patient demonstrated marked bone marrow uptake, reflecting the hypercellular marrow with fibrosis. DWI revealed diffusely high signal intensities in both the primary and secondary MF patients. CONCLUSION: 18F-FLT PET can be used to noninvasively assess whole-body bone marrow proliferative activity and DWI may reflect the different aspects of bone marrow pathophysiology from 18F-FLT PET. 18F-FLT PET/MRI is useful for the diagnosis and monitoring of BMFS, except for the differentiation between non-severe AA and hypo-MDS, and the prediction of progression to leukemia. More... »

PAGES

16

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13550-019-0490-0

DOI

http://dx.doi.org/10.1186/s13550-019-0490-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112168852

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30771115


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Fukui", 
          "id": "https://www.grid.ac/institutes/grid.163577.1", 
          "name": [
            "Biomedical Imaging Research Center, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, 910-1193, Fukui, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tsujikawa", 
        "givenName": "Tetsuya", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Fukui", 
          "id": "https://www.grid.ac/institutes/grid.163577.1", 
          "name": [
            "Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, 910-1193, Fukui, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tasaki", 
        "givenName": "Toshiki", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Fukui", 
          "id": "https://www.grid.ac/institutes/grid.163577.1", 
          "name": [
            "Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, 910-1193, Fukui, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hosono", 
        "givenName": "Naoko", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Fukui", 
          "id": "https://www.grid.ac/institutes/grid.163577.1", 
          "name": [
            "Biomedical Imaging Research Center, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, 910-1193, Fukui, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mori", 
        "givenName": "Tetsuya", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Fukui", 
          "id": "https://www.grid.ac/institutes/grid.163577.1", 
          "name": [
            "Biomedical Imaging Research Center, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, 910-1193, Fukui, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Makino", 
        "givenName": "Akira", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Fukui", 
          "id": "https://www.grid.ac/institutes/grid.163577.1", 
          "name": [
            "Biomedical Imaging Research Center, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, 910-1193, Fukui, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kiyono", 
        "givenName": "Yasushi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Houston Methodist", 
          "id": "https://www.grid.ac/institutes/grid.63368.38", 
          "name": [
            "Houston Methodist Research Institute, Weill Cornell Medicine, 6670 Bertner Ave, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zanotti-Fregonara", 
        "givenName": "Paolo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Fukui", 
          "id": "https://www.grid.ac/institutes/grid.163577.1", 
          "name": [
            "Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, 910-1193, Fukui, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamauchi", 
        "givenName": "Takahiro", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Fukui", 
          "id": "https://www.grid.ac/institutes/grid.163577.1", 
          "name": [
            "Biomedical Imaging Research Center, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, 910-1193, Fukui, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okazawa", 
        "givenName": "Hidehiko", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12185-013-1324-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003795530", 
          "https://doi.org/10.1007/s12185-013-1324-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jmri.24548", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007117339"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2016.206", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009854920", 
          "https://doi.org/10.1038/leu.2016.206"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2014-0056", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016231877"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1148/radiol.11110474", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026693762"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.acra.2015.05.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028789546"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1148/radiol.13131529", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034071364"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-014-2902-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036214761", 
          "https://doi.org/10.1007/s00259-014-2902-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00330-010-1758-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037667174", 
          "https://doi.org/10.1007/s00330-010-1758-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00330-010-1758-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037667174", 
          "https://doi.org/10.1007/s00330-010-1758-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejrad.2010.03.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041441251"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0b013e31820aa1a1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042504399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.1988.tb02460.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043302997"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.114.152983", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045774742"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074670692", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077303933", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3233/cbm-2009-0116", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078050035"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.116.188508", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084419621"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13550-017-0326-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091810324", 
          "https://doi.org/10.1186/s13550-017-0326-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2352-3026(17)30215-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1099664183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11547-018-0935-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106820613", 
          "https://doi.org/10.1007/s11547-018-0935-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: Bone marrow failure syndrome (BMFS) is a heterogeneous group of disorders associated with single- or multiple-lineage cytopenia and failure of normal hematopoiesis. We assessed the feasibility of integrated PET/MRI with 3'-deoxy-3'-18F-fluorothymidine (18F-FLT) to assess the pathophysiology of whole-body bone marrow for the diagnosis and monitoring of BMFS. Twenty-five consecutive patients with BMFS underwent a pre-treatment 18F-FLT PET/MRI scan. They included 7 patients with aplastic anemia (AA), 16 with myelodysplastic syndrome (MDS), and 2 with myeloproliferative neoplasms (MPNs), primary myelofibrosis (MF), and secondary [post-essential thrombocythemia (post-ET)] MF. Two of the seven AA patients underwent a post-treatment scan. Eight of the 16 MDS patients who exhibited decreased 18F-FLT uptake in the pelvis were considered to have hypoplastic MDS (hypo-MDS). 18F-FLT PET and diffusion-weighted imaging (DWI) were visually and quantitatively evaluated.\nRESULTS: The 18F-FLT uptake in the ilium was strongly correlated with bone marrow cellularity based on biopsy samples (\u03c1\u2009=\u20090.85). AA patients exhibited heterogeneously decreased uptake of 18F-FLT according to disease severity. Multiple 18F-FLT foci were observed in the proximal extremities, and they were in the central skeleton in severe AA patients. Post-treatment 18F-FLT PET scans of severe AA patients reflected the response of hematopoietic activity to treatment. MDS patients had marked 18F-FLT uptake in the central skeleton and proximal extremities, whereas hypo-MDS patients had heterogeneously decreased uptake, similar to that of non-severe AA patients. 18F-FLT PET and DWI were unable to predict the progression to leukemia for both MDS and hypo-MDS patients. A primary MF patient had slightly decreased 18F-FLT uptake in the central skeleton, but marked expansion of bone marrow activity to the distal extremities and high uptake of tracer in the extremely enlarged spleen (extramedullary hematopoiesis). In contrast, a secondary (post-ET) MF patient demonstrated marked bone marrow uptake, reflecting the hypercellular marrow with fibrosis. DWI revealed diffusely high signal intensities in both the primary and secondary MF patients.\nCONCLUSION: 18F-FLT PET can be used to noninvasively assess whole-body bone marrow proliferative activity and DWI may reflect the different aspects of bone marrow pathophysiology from 18F-FLT PET. 18F-FLT PET/MRI is useful for the diagnosis and monitoring of BMFS, except for the differentiation between non-severe AA and hypo-MDS, and the prediction of progression to leukemia.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13550-019-0490-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1045165", 
        "issn": [
          "2191-219X"
        ], 
        "name": "EJNMMI Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "name": "18F-FLT PET/MRI for bone marrow failure syndrome-initial experience", 
    "pagination": "16", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "81760d2d43e6e6ce1af4e436fe5df9d10a7d88a2646e56755090fbb92e703054"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30771115"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101560946"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13550-019-0490-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112168852"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13550-019-0490-0", 
      "https://app.dimensions.ai/details/publication/pub.1112168852"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000354_0000000354/records_11707_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13550-019-0490-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13550-019-0490-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13550-019-0490-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13550-019-0490-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13550-019-0490-0'


 

This table displays all metadata directly associated to this object as RDF triples.

183 TRIPLES      21 PREDICATES      49 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13550-019-0490-0 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N2c669cfd3d284833a81e8f2eb8b1888a
4 schema:citation sg:pub.10.1007/s00259-014-2902-8
5 sg:pub.10.1007/s00330-010-1758-y
6 sg:pub.10.1007/s11547-018-0935-y
7 sg:pub.10.1007/s12185-013-1324-x
8 sg:pub.10.1038/leu.2016.206
9 sg:pub.10.1186/s13550-017-0326-8
10 https://app.dimensions.ai/details/publication/pub.1074670692
11 https://app.dimensions.ai/details/publication/pub.1077303933
12 https://doi.org/10.1002/jmri.24548
13 https://doi.org/10.1016/j.acra.2015.05.011
14 https://doi.org/10.1016/j.ejrad.2010.03.011
15 https://doi.org/10.1016/s2352-3026(17)30215-6
16 https://doi.org/10.1097/rlu.0b013e31820aa1a1
17 https://doi.org/10.1111/j.1365-2141.1988.tb02460.x
18 https://doi.org/10.1148/radiol.11110474
19 https://doi.org/10.1148/radiol.13131529
20 https://doi.org/10.1634/theoncologist.2014-0056
21 https://doi.org/10.2967/jnumed.114.152983
22 https://doi.org/10.2967/jnumed.116.188508
23 https://doi.org/10.3233/cbm-2009-0116
24 schema:datePublished 2019-12
25 schema:datePublishedReg 2019-12-01
26 schema:description BACKGROUND: Bone marrow failure syndrome (BMFS) is a heterogeneous group of disorders associated with single- or multiple-lineage cytopenia and failure of normal hematopoiesis. We assessed the feasibility of integrated PET/MRI with 3'-deoxy-3'-18F-fluorothymidine (18F-FLT) to assess the pathophysiology of whole-body bone marrow for the diagnosis and monitoring of BMFS. Twenty-five consecutive patients with BMFS underwent a pre-treatment 18F-FLT PET/MRI scan. They included 7 patients with aplastic anemia (AA), 16 with myelodysplastic syndrome (MDS), and 2 with myeloproliferative neoplasms (MPNs), primary myelofibrosis (MF), and secondary [post-essential thrombocythemia (post-ET)] MF. Two of the seven AA patients underwent a post-treatment scan. Eight of the 16 MDS patients who exhibited decreased 18F-FLT uptake in the pelvis were considered to have hypoplastic MDS (hypo-MDS). 18F-FLT PET and diffusion-weighted imaging (DWI) were visually and quantitatively evaluated. RESULTS: The 18F-FLT uptake in the ilium was strongly correlated with bone marrow cellularity based on biopsy samples (ρ = 0.85). AA patients exhibited heterogeneously decreased uptake of 18F-FLT according to disease severity. Multiple 18F-FLT foci were observed in the proximal extremities, and they were in the central skeleton in severe AA patients. Post-treatment 18F-FLT PET scans of severe AA patients reflected the response of hematopoietic activity to treatment. MDS patients had marked 18F-FLT uptake in the central skeleton and proximal extremities, whereas hypo-MDS patients had heterogeneously decreased uptake, similar to that of non-severe AA patients. 18F-FLT PET and DWI were unable to predict the progression to leukemia for both MDS and hypo-MDS patients. A primary MF patient had slightly decreased 18F-FLT uptake in the central skeleton, but marked expansion of bone marrow activity to the distal extremities and high uptake of tracer in the extremely enlarged spleen (extramedullary hematopoiesis). In contrast, a secondary (post-ET) MF patient demonstrated marked bone marrow uptake, reflecting the hypercellular marrow with fibrosis. DWI revealed diffusely high signal intensities in both the primary and secondary MF patients. CONCLUSION: 18F-FLT PET can be used to noninvasively assess whole-body bone marrow proliferative activity and DWI may reflect the different aspects of bone marrow pathophysiology from 18F-FLT PET. 18F-FLT PET/MRI is useful for the diagnosis and monitoring of BMFS, except for the differentiation between non-severe AA and hypo-MDS, and the prediction of progression to leukemia.
27 schema:genre research_article
28 schema:inLanguage en
29 schema:isAccessibleForFree false
30 schema:isPartOf N8f964c9080814d7ba38129a3d40ad365
31 Nd4af2d3995564ae5a1a991b8b7b3b0ff
32 sg:journal.1045165
33 schema:name 18F-FLT PET/MRI for bone marrow failure syndrome-initial experience
34 schema:pagination 16
35 schema:productId N58d803e1e2a7486cb6d643f84dfec249
36 N99674dad48e048ec82e23521124bbd0a
37 N9d833dd4b6e34ead8e68a16b701b1ea2
38 N9eefd63c8f2e4cd28a1211c9a9c5dbf8
39 Nb45e4aaa45f1407db4f264a566fc9c5d
40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112168852
41 https://doi.org/10.1186/s13550-019-0490-0
42 schema:sdDatePublished 2019-04-11T11:19
43 schema:sdLicense https://scigraph.springernature.com/explorer/license/
44 schema:sdPublisher N008fd1c413d549d0b4efdd8cdf25716d
45 schema:url https://link.springer.com/10.1186%2Fs13550-019-0490-0
46 sgo:license sg:explorer/license/
47 sgo:sdDataset articles
48 rdf:type schema:ScholarlyArticle
49 N008fd1c413d549d0b4efdd8cdf25716d schema:name Springer Nature - SN SciGraph project
50 rdf:type schema:Organization
51 N0f5de9fefcbd4cfda8fdb3f6785a8070 rdf:first Nf4169541960f4ba285e6c15ff7ef8f70
52 rdf:rest N1eee3e74d1ae4ff9bb70c68c8855c247
53 N1eee3e74d1ae4ff9bb70c68c8855c247 rdf:first N81cdfa825d5842239436de2cdf3192db
54 rdf:rest N427be893064544568d8f79cf561cbb47
55 N2c669cfd3d284833a81e8f2eb8b1888a rdf:first Nfc9e184e75714ba09d9ad457b711d769
56 rdf:rest Nd4183a34b7aa424ea5a86dcdefc92ce5
57 N38937b525523461a923112660ccb2511 rdf:first N51ef4a36121c4c4e8e7a7fb7d4547026
58 rdf:rest N0f5de9fefcbd4cfda8fdb3f6785a8070
59 N3e03771e2cac4820a58a21b360c03015 schema:affiliation https://www.grid.ac/institutes/grid.163577.1
60 schema:familyName Hosono
61 schema:givenName Naoko
62 rdf:type schema:Person
63 N427be893064544568d8f79cf561cbb47 rdf:first Na84e1f88d8be4a98914b4d674484bdb0
64 rdf:rest Nb30545726e0341c38f656a9878741ceb
65 N4f896e5c27be478f8f4fb2770b29ce98 schema:affiliation https://www.grid.ac/institutes/grid.163577.1
66 schema:familyName Mori
67 schema:givenName Tetsuya
68 rdf:type schema:Person
69 N51ef4a36121c4c4e8e7a7fb7d4547026 schema:affiliation https://www.grid.ac/institutes/grid.163577.1
70 schema:familyName Makino
71 schema:givenName Akira
72 rdf:type schema:Person
73 N58d803e1e2a7486cb6d643f84dfec249 schema:name readcube_id
74 schema:value 81760d2d43e6e6ce1af4e436fe5df9d10a7d88a2646e56755090fbb92e703054
75 rdf:type schema:PropertyValue
76 N713648f122f64a219996a7c4244f59a2 schema:affiliation https://www.grid.ac/institutes/grid.163577.1
77 schema:familyName Tasaki
78 schema:givenName Toshiki
79 rdf:type schema:Person
80 N81cdfa825d5842239436de2cdf3192db schema:affiliation https://www.grid.ac/institutes/grid.63368.38
81 schema:familyName Zanotti-Fregonara
82 schema:givenName Paolo
83 rdf:type schema:Person
84 N8f964c9080814d7ba38129a3d40ad365 schema:volumeNumber 9
85 rdf:type schema:PublicationVolume
86 N9903e962e4cc40f2ace17135c015a033 rdf:first N4f896e5c27be478f8f4fb2770b29ce98
87 rdf:rest N38937b525523461a923112660ccb2511
88 N99674dad48e048ec82e23521124bbd0a schema:name doi
89 schema:value 10.1186/s13550-019-0490-0
90 rdf:type schema:PropertyValue
91 N9d833dd4b6e34ead8e68a16b701b1ea2 schema:name pubmed_id
92 schema:value 30771115
93 rdf:type schema:PropertyValue
94 N9eefd63c8f2e4cd28a1211c9a9c5dbf8 schema:name nlm_unique_id
95 schema:value 101560946
96 rdf:type schema:PropertyValue
97 Na84e1f88d8be4a98914b4d674484bdb0 schema:affiliation https://www.grid.ac/institutes/grid.163577.1
98 schema:familyName Yamauchi
99 schema:givenName Takahiro
100 rdf:type schema:Person
101 Nb18b7e0618a64f568654cc9b33f2c285 rdf:first N3e03771e2cac4820a58a21b360c03015
102 rdf:rest N9903e962e4cc40f2ace17135c015a033
103 Nb30545726e0341c38f656a9878741ceb rdf:first Nbb99eb1ee9b84350a7d32495fd1b5282
104 rdf:rest rdf:nil
105 Nb45e4aaa45f1407db4f264a566fc9c5d schema:name dimensions_id
106 schema:value pub.1112168852
107 rdf:type schema:PropertyValue
108 Nbb99eb1ee9b84350a7d32495fd1b5282 schema:affiliation https://www.grid.ac/institutes/grid.163577.1
109 schema:familyName Okazawa
110 schema:givenName Hidehiko
111 rdf:type schema:Person
112 Nd4183a34b7aa424ea5a86dcdefc92ce5 rdf:first N713648f122f64a219996a7c4244f59a2
113 rdf:rest Nb18b7e0618a64f568654cc9b33f2c285
114 Nd4af2d3995564ae5a1a991b8b7b3b0ff schema:issueNumber 1
115 rdf:type schema:PublicationIssue
116 Nf4169541960f4ba285e6c15ff7ef8f70 schema:affiliation https://www.grid.ac/institutes/grid.163577.1
117 schema:familyName Kiyono
118 schema:givenName Yasushi
119 rdf:type schema:Person
120 Nfc9e184e75714ba09d9ad457b711d769 schema:affiliation https://www.grid.ac/institutes/grid.163577.1
121 schema:familyName Tsujikawa
122 schema:givenName Tetsuya
123 rdf:type schema:Person
124 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
125 schema:name Medical and Health Sciences
126 rdf:type schema:DefinedTerm
127 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
128 schema:name Clinical Sciences
129 rdf:type schema:DefinedTerm
130 sg:journal.1045165 schema:issn 2191-219X
131 schema:name EJNMMI Research
132 rdf:type schema:Periodical
133 sg:pub.10.1007/s00259-014-2902-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036214761
134 https://doi.org/10.1007/s00259-014-2902-8
135 rdf:type schema:CreativeWork
136 sg:pub.10.1007/s00330-010-1758-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1037667174
137 https://doi.org/10.1007/s00330-010-1758-y
138 rdf:type schema:CreativeWork
139 sg:pub.10.1007/s11547-018-0935-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1106820613
140 https://doi.org/10.1007/s11547-018-0935-y
141 rdf:type schema:CreativeWork
142 sg:pub.10.1007/s12185-013-1324-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1003795530
143 https://doi.org/10.1007/s12185-013-1324-x
144 rdf:type schema:CreativeWork
145 sg:pub.10.1038/leu.2016.206 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009854920
146 https://doi.org/10.1038/leu.2016.206
147 rdf:type schema:CreativeWork
148 sg:pub.10.1186/s13550-017-0326-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091810324
149 https://doi.org/10.1186/s13550-017-0326-8
150 rdf:type schema:CreativeWork
151 https://app.dimensions.ai/details/publication/pub.1074670692 schema:CreativeWork
152 https://app.dimensions.ai/details/publication/pub.1077303933 schema:CreativeWork
153 https://doi.org/10.1002/jmri.24548 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007117339
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/j.acra.2015.05.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028789546
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1016/j.ejrad.2010.03.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041441251
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1016/s2352-3026(17)30215-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1099664183
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1097/rlu.0b013e31820aa1a1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042504399
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1111/j.1365-2141.1988.tb02460.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1043302997
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1148/radiol.11110474 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026693762
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1148/radiol.13131529 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034071364
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1634/theoncologist.2014-0056 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016231877
170 rdf:type schema:CreativeWork
171 https://doi.org/10.2967/jnumed.114.152983 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045774742
172 rdf:type schema:CreativeWork
173 https://doi.org/10.2967/jnumed.116.188508 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084419621
174 rdf:type schema:CreativeWork
175 https://doi.org/10.3233/cbm-2009-0116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078050035
176 rdf:type schema:CreativeWork
177 https://www.grid.ac/institutes/grid.163577.1 schema:alternateName University of Fukui
178 schema:name Biomedical Imaging Research Center, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, 910-1193, Fukui, Japan
179 Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, 910-1193, Fukui, Japan
180 rdf:type schema:Organization
181 https://www.grid.ac/institutes/grid.63368.38 schema:alternateName Houston Methodist
182 schema:name Houston Methodist Research Institute, Weill Cornell Medicine, 6670 Bertner Ave, 77030, Houston, TX, USA
183 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...